Minneapolis, MNNCT05934747Now EnrollingIRB Ready

Parkinson's Disease and Parkinsonism Clinical Trial in Minneapolis, MN

Access cutting-edge parkinson's disease and parkinsonism treatment through this clinical trial at a research site in Minneapolis. Study-provided care at no cost to qualified participants.

Sponsored by University of Minnesota

Quick Self-Assessment

See if you qualify for this Minneapolis location

Preparing your pre-screening questions…

Expert Care in Minneapolis

Access parkinson's disease and parkinsonism specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related parkinson's disease and parkinsonism treatment provided free

Apply for This Minneapolis Location

Check if you qualify for this parkinson's disease and parkinsonism clinical trial in Minneapolis, MN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Minneapolis

    Convenient for MN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Minneapolis site if eligible
  4. 4Begin participation

About This Parkinson's Disease and Parkinsonism Study in Minneapolis

In Parkinson's disease (PD) patients undergoing standard-of-care Deep Brain Stimulation (DBS) therapy, to compare the effect on Parkinson's symptoms of two different neurostimulator settings designed to differ from each other as much as possible with respect to how much they activate two different neuroanatomical structures: the axonal pathway from Globus Pallidus (GP) to Pedunculopontine Nucleus (PPN), and the axonal pathway from PPN to GP.

Sponsor: University of Minnesota

Who Can Participate

Inclusion Criteria

Diagnosis of Parkinson's Disease
Bilateral DBS in STN or GP
At least 3 months after lead implantation
Montreal Cognitive Assessment (MoCA): MoCA=23+ OR: If MoCA score is 23 or less, UBACC will be performed to ensure capacity to consent. If UBACC results are unclear, the MacCAT-CR will be performed. Failed or unclear MacCAT-CR results will exclude the study candidate.
Between 18-85 years of age
Has undergone pre-operative 7T MRI (as part of protocol #1210M22183 or standard-of-care) and post-operative CT imaging (standard of care). 8.2 Exclusion Criteria:
Inability to walk in the off-med, off-stimulation condition (even with safety harness)
Gait impaired significantly by a condition other than PD
Breaks or shorts in active contacts
IPG battery nearing end of life (in patients with primary-cell IPGs)
Females who are nursing or pregnant

Exclusion Criteria

Inability to walk in the off-med, off-stimulation condition (even with safety harness)
Gait impaired significantly by a condition other than PD
Breaks or shorts in active contacts
IPG battery nearing end of life (in patients with primary-cell IPGs)
Females who are nursing or pregnant

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Minneapolis?

Yes, this clinical trial (NCT05934747) has an active research site in Minneapolis, MN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Parkinson's Disease and Parkinsonism Treatment Options in Minneapolis, MN

If you're searching for parkinson's disease and parkinsonism treatment options in Minneapolis, MN, this clinical trial (NCT05934747) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Minneapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced parkinson's disease and parkinsonism specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all parkinson's disease and parkinsonism clinical trials near you to find additional studies recruiting in your area.

More Parkinsons Disease Trials in Minneapolis, MN

See all parkinsons disease clinical trials recruiting in Minneapolis — not just this study.

Browse Parkinsons Disease Trials in Minneapolis →

Ready to Join in Minneapolis?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Minneapolis, MN